Your browser doesn't support javascript.
loading
Emerging strategies for delivering antiangiogenic therapies to primary and metastatic brain tumors.
Askoxylakis, Vasileios; Arvanitis, Costas D; Wong, Christina S F; Ferraro, Gino B; Jain, Rakesh K.
Afiliação
  • Askoxylakis V; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital (MGH), Harvard Medical School (HMS), Boston, MA, 02114, USA.
  • Arvanitis CD; School of Mechanical Engineering, Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
  • Wong CSF; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital (MGH), Harvard Medical School (HMS), Boston, MA, 02114, USA.
  • Ferraro GB; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital (MGH), Harvard Medical School (HMS), Boston, MA, 02114, USA.
  • Jain RK; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital (MGH), Harvard Medical School (HMS), Boston, MA, 02114, USA. Electronic address: jain@steele.mgh.harvard.edu.
Adv Drug Deliv Rev ; 119: 159-174, 2017 09 15.
Article em En | MEDLINE | ID: mdl-28648712
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Inibidores da Angiogênese Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Inibidores da Angiogênese Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article